Article
Recombinant adeno-associated virus vector-based gene transfer for defects in oxidative metabolism.
Human gene therapy - 10 Oct 2000
Owen R I V, Lewin A P, Peel A, Wang J, Guy J, Hauswirth W W, Stacpoole P W, Flotte T R
Abstract excerpt
Defects in oxidative metabolism may be caused by mutations either in nuclear genes or in mitochondrial DNA (mtDNA). We tested the hypothesis that recombinant adeno-associated virus (rAAV) could be used to complement mtDNA mutations. AAV vector constructs were designed to express the reporter gene encoding green fluorescent protein (GFP), fused to a targeting presequence that directed GFP to be translocated into...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
